Effects of thermotherapy on Th1/Th2 cells in esophageal cancer patients treated with radiotherapy

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 5, 2014, Pages 2359-2362

  Hong, Mei ^a   Jiang, Zao ^b   Zhou, Ying Feng ^c  

^a Nanjing Thoracic Hospital   (China)

^b AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

^c Department of Gastroenterology   (China)

Author keywords

Double radiofrequency hyperthermia; Esophageal cancer; Radiotherapy; Th1; Th2

Indexed keywords

AGED; ESOPHAGEAL NEOPLASMS; FEMALE; HUMAN; HYPERTHERMIC THERAPY; MALE; MIDDLE AGED; PROCEDURES; RADIATION RESPONSE; TH1 CELL; TH2 CELL;

AGED; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; TH1 CELLS; TH2 CELLS;

EID: 84899061428     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.5.2359     Document Type: Article

References (24)

1. Abbas AK, Murphy KM, Sher A (1996). Function diversity of helper T lymphocytes. Nature, 383, 787-93.
2. Ahlers O, Hilderbrant B, Dieing A (2005). Stress induced changes in lymphocyte subpopulations and associated cytokines during whole body hyperthermia of 41.8-42.2 degree C. Eur J Appl Physiol, 95, 298-306.
3. Almhanna K, Shridhar R, Meredith KL (2013). Neoadjuvant or adjuvant therapy for resectable esophageal cancer: is there a standard of care. Cancer Control, 20, 89-96.
4. Bottaro DP, Liotta LA (2003). Cancer: Out of air is not out of action. Nature, 423, 593-5.
5. Braumüller H, Wieder T, Brenner E, et al (2013). T-helper-1-cell cytokines drive cancer into senescence. Nature, 494, 361-5.
6. Dings RP, Loren ML, Zhang Y, et al (2011). Tumour thermotolerance, a physiological phenomenon involving vessel normalisation. Int J Hyperthermia, 27, 42-52.
7. Griffin RJ, Dings RP, Jamshidi-Parsian A, et al (2010). Mild temperature hyperthermia and radiation therapy: Role of tumour vascular thermotolerance and relevant physiological factors. Int J Hyperthermia, 26, 256-63.
8. Kobayashi M, Kubo T, Komatsu K, et al (2013). Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinomapatients treated with molecular targeted therapy. Med Oncol, 30, 556.
9. Magdalena C, Anna D, Krystyna S, et al (2004). Sera of lung cancer patients affect the release of Th1, Th2 and monocytederived cytokines, and the expression of TL-2Ra by normal, stimulated mononuclear cells. Mol Cell Biol Lett, 9, 69-81.
10. Morita M, Kuwano H, Araki K, et al (2001). Prognostic significance of lymphocyte infiltration following properative chemoradiotherapy and hyperthermia for esoph-ageal cancer. Int J Radiat Oncol Biol Phys, 49, 1259-66.
11. Mosmann TR, Cherwinski H, Bond MW, et al (1986). Two types of murme helper Tcell clone I. Defintion according to profiles of lymphokine activities and secreted proteins. J Immunol, 136, 2348-57.
12. Rotstein S, Blomgren H, Petrini B, et al (1985). Long term effects on the immune system following local radiation therapy for breast cancer. I. Cellular composition of the peripheral blood lymphocyte population. Int J Radiat Oncol Biol Phys, 11, 921-5.
13. Cui YH, Liang HJ, Zhang QQ, et al (2012). Radiosensitivity enhancement by arsenic trioxide in conjunction with hyperthermia in the EC-1 esophageal carcinoma cell line. Asian Pac J Cancer Prev, 13, 1693-7.
14. Wang DC, Zhang Y, Chen HY, et al (2012). Hyperthermia promotes apoptosis and suppresses invasion in C6 rat glioma cells. Asian Pac J Cancer Prev. 13, 3239-45.
15. Zhou HM, Feng B, Zhao HC, et al (2012). Antitumor effects of hyperthermic CO2 pneumoperitoneum on human gastric cancer cells. Asian Pac J Cancer Prev, 13, 117-22.
16. Saga T, Sakahara H, Nakamoto Y, et al (2002). Enhancement of the therapeutic outcome of radio-immunotherapy by combination with wholebody mild hyperthermia. Eur J Cancer, 86, 1579-603.
17. Song PI, Liang H, Fan JH, et al (2011). Long-term survival after esophagectomy for early esophageal squamous cell carcinoma in Linxian, China. J Surg Oncol, 104, 176-80.
18. Tsukui T, Hildesheim A, Schiffman MH, et al (1996). Interleukin-2 production in vitro by perrpheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res, 56, 3967-74.
19. Wang Q, Chen DY (2009). Effect of Aidi injection on peripheral blood expression of Th1/Th2 transcription factors and cytokines in patients with esophageal squamous cell carcinoma during radiotherapy. Chinese J Integ Tradition West Med, 29, 394-7.
20. Wang XY, Kazim L, Repasky EA, et al (2001). Characterization of heat shock protein 110 and glucose-related protein 170 as cancer vaccines and the effect of fever range hyperthermia on accine activity. J Immunol, 166, 490-7.
21. Westerterp M, Boermeester MA, Omloo JM, et al (2008). Differential responses of cellular immunity in patients undergoing neoadjuvant therapy followed by surgery forcarcinoma of the oesophagus. Cancer Immunol Immunother, 57, 1837-47.
22. Yuguchi T, Saito M, Yokoyama Y, et al (2002). Combined use of hyperthermia and irradiation cause antiproliferative activity and cell death to human esophageal cell carcinoma cells-mainly cell cycle examination. Hum Cell, 15, 33-42.
23. Zhao JX, Li XF, Wang XX (2007). Effects of body-resistance strengthening and tumor-suppressing granules on immune adhesion function of red blood cells and expression of metastasis protein CD44 in tumor cells of patients with esophageal carcinoma. World J Gastroenterol, 13, 4360-4.
24. Zolzer F, Streffer C (2001). G2-Phase delays after irradiation and/or heat treatment as assessed by two-parameter flow cytometry. Radiat Res, 155, 50-6.